Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1007/s11307-016-0951-z

[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer

..., Farrokh Dehdashti
66
Molecular Imaging and Biology3.10
Volume: 18, Issue: 6, Pages: 952 - 959
Published: May 4, 2016
Abstract
The purpose of the present study is to evaluate safety, human radiation dosimetry, and optimal imaging time of [89Zr]trastuzumab in patients with HER2-positive breast cancer. Twelve women with HER2-positive breast cancer underwent [89Zr]trastuzumab positron emission tomography (PET)/X-ray computed tomography (CT) twice within 7 days post-injection. Biodistribution data from whole-torso PET/CT images and organ time-activity curves were created...
Paper Fields
Paper Details
Title
[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
DOI
doi.org/10.1007/s11307-016-0951-z
Published Date
May 4, 2016
Journal
Molecular Imaging and Biology
Volume
18
Issue
6
Pages
952 - 959
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.